Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
2012 1
2013 2
2015 1
2016 1
2021 2
2022 3
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Using a learning health system to understand the mismatch between medicines supply and actual medicines use among adults with cystic fibrosis.
Bevan A, Hoo ZH, Totton N, Girling C, Davids IR, Whelan P, Antrobus S, Ainsworth J, Buchan I, Anderson A, Bourke S, Doe S, Echevarria C, Taylor J, Bell NJ, Bateman K, Jones C, Moran P, Fitch G, Martin M, McGowan A, Morrow S, Seabridge H, Bush N, Daniels T, Lee K, Robson N, Shiferaw D, Sweis D, Thomas R, Faulkner J, Flight WG, Poole S, Warnock L, Allenby MI, Carroll M, Daniels TV, Dunn H, Nightingale JA, Shepherd E, Ohri C, Gadsby J, Range S, Tature D, Barr HL, Dawson S, Dewar J, Miller B, Saini G, Galey P, Johnson J, Pasteur MC, Derry D, Gledhill H, Lawson A, Thomas M, Waine D, Cunningham J, Damani A, Higton A, Orchard C, Carolan C, Tahir M, Plummer A, Hutchings M, Edenborough FP, Curley R, Wildman MJ. Bevan A, et al. Among authors: galey p. J Cyst Fibros. 2022 Mar;21(2):323-331. doi: 10.1016/j.jcf.2021.09.007. Epub 2021 Sep 23. J Cyst Fibros. 2022. PMID: 34565705 Free article.
Optimising outcomes for adults with cystic fibrosis taking CFTR modulators by individualising care: Personalised data linkage to understand treatment optimisation (PLUTO), a novel clinical framework.
Sandler RD, Anderson A, Barnett T, Bourke SJ, Cameron S, Chapman SJ, Choyce J, Daniels T, Daniels T, Dawson S, Doe S, Dooney M, Echevarria C, Galey P, Fitch G, Lai LYH, Nightingale JA, Thomas M, Thompson R, Whitehouse J, Warnock L, Waine D, Withers N, Hoo ZH, Wildman MJ. Sandler RD, et al. Among authors: galey p. Respir Med. 2025 Apr;239:107995. doi: 10.1016/j.rmed.2025.107995. Epub 2025 Feb 15. Respir Med. 2025. PMID: 39961395 Review.
Self-management intervention to reduce pulmonary exacerbations by supporting treatment adherence in adults with cystic fibrosis: a randomised controlled trial.
Wildman MJ, O'Cathain A, Maguire C, Arden MA, Hutchings M, Bradley J, Walters SJ, Whelan P, Ainsworth J, Buchan I, Mandefield L, Sutton L, Tappenden P, Elliott RA, Hoo ZH, Drabble SJ, Beever D; CFHealthHub Study Team. Wildman MJ, et al. Thorax. 2022 May;77(5):461-469. doi: 10.1136/thoraxjnl-2021-217594. Epub 2021 Sep 23. Thorax. 2022. PMID: 34556552 Free PMC article. Clinical Trial.
Corrigendum to "Using a learning health system to understand the mismatch between medicines supply and actual medicines use among adults with cystic fibrosis" [J Cyst Fibros (2022), 21/2, 323-331].
Bevan A, Hoo ZH, Totton N, Girling C, Davids IR, Whelan P, Antrobus S, Ainsworth J, Buchan I, Anderson A, Bourke S, Doe S, Echevarria C, Taylor J, Bell NJ, Bateman K, Jones C, Moran P, Fitch G, Martin M, McGowan A, Morrow S, Seabridge H, Bush N, Daniels T, Lee K, Robson N, Shiferaw D, Sweis D, Thomas R, Faulkner J, Flight WG, Poole S, Warnock L, Allenby MI, Carroll M, Daniels TV, Dunn H, Nightingale JA, Shepherd E, Ohri C, Gadsby J, Range S, Tature D, Barr HL, Dawson S, Dewar J, Miller B, Saini G, Galey P, Johnson J, Pasteur MC, Derry D, Gledhill H, Lawson A, Thomas M, Waine D, Cunningham J, Damani A, Higton A, Orchard C, Carolan C, Tahir M, Plummer A, Hutchings M, Edenborough FP, Curley R, Wildman MJ. Bevan A, et al. Among authors: galey p. J Cyst Fibros. 2022 Sep;21(5):893-897. doi: 10.1016/j.jcf.2022.07.011. Epub 2022 Jul 28. J Cyst Fibros. 2022. PMID: 35907767 Free article. No abstract available.
The Cost Effectiveness of Maintenance Schedules Following Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease: An Economic Evaluation Alongside a Randomised Controlled Trial.
Burns DK, Wilson EC, Browne P, Olive S, Clark A, Galey P, Dix E, Woodhouse H, Robinson S, Wilson A. Burns DK, et al. Among authors: galey p. Appl Health Econ Health Policy. 2016 Feb;14(1):105-15. doi: 10.1007/s40258-015-0199-9. Appl Health Econ Health Policy. 2016. PMID: 26346590 Free PMC article. Clinical Trial.
[Cirrhosis im algerian moslems].
CLAUDE R, EISENBETH R, FOURRIER A, GALEY P, LE GO, LEBON J. CLAUDE R, et al. Among authors: galey p. Rev Int Hepatol. 1956;6(5):497-528. Rev Int Hepatol. 1956. PMID: 13359891 French. No abstract available.
Corrigendum to "Optimising outcomes for adults with Cystic Fibrosis taking CFTR modulators by individualising care: Personalised data linkage to understand treatment optimisation (PLUTO), a novel clinical framework" [Respirat. Med. 239 (2025)].
Sandler RD, Anderson A, Barnett T, Bourke SJ, Cameron S, Chapman SJ, Choyce J, Daniels T, Daniels T, Dawson S, Doe S, Dooney M, Echevarria C, Galey P, Fitch G, Lai LY, Nightingale JA, Thomas M, Thompson R, Whitehouse J, Warnock L, Waine D, Withers N, Hoo ZH, Wildman MJ. Sandler RD, et al. Among authors: galey p. Respir Med. 2025 May;241:108016. doi: 10.1016/j.rmed.2025.108016. Epub 2025 Mar 13. Respir Med. 2025. PMID: 40087032